STAMPEDE otherwise follows a line of randomized trials (e.g., MAST, TAXOMET, IMPROVE) that have failed to prove cancer ...

Camrelizumab, an investigational immunotherapy, on top of adjuvant capecitabine (Xeloda) and radiotherapy, improved survival ...

Cancer treatment is becoming increasingly personalised and oncologists know their enemy in more intimate detail than ever ...

A new study has opened in Manchester which could improve screening and early detection of lung cancer for high-risk Hodgkin ...

Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...

They want to gain a deeper understanding of why the disease behaves differently in Asian patients. Read more at ...

The FDA has granted orphan status to Arcus Biosciences’ CD73 inhibitor quemliclustat for metastatic pancreatic cancer, as the ...

Supporters who mistakenly thought a new law eliminated a costly barrier to breast cancer diagnostic screening in cancer-prone Iowa feel misled.

A friend of mine was recently diagnosed with a melanoma, an aggressive form of skin cancer that had spread throughout their ...

Australia has launched its first lung cancer screening program, which targets current and recent smokers with biennial ...

The Central Texas Cancer Survivor Party, part of Cattle Baron’s Ball, will be held at 5:30 p.m. July 22 at the Texas Sports ...

Compassionate-use lurbinectedin demonstrates modest yet consistent efficacy and is well tolerated in patients with ...